Sponsor message

New 100% online training course from FishVet Group and Benchmark Knowledge Services on The Health and Welfare of Atlantic Salmon

Scots salmon producers question sea louse treatment ruling

30 June 2017, at 1:47pm

The Scottish salmon industry has decided to commission new research after calling into question SEPA’s decision to cut back on the use of the sea louse treatment emamectin benzoate (SLICE) by 60 percent.

Following the publication of the WRc Report by the Scottish Environmental Protection Agency (SEPA) earlier this week, the Scottish Salmon Producers Organisation (SSPO) has announced that it is to commission further independent research "to properly inform the discussion about the potential impact of emamectin benzoate".

Scott Landsburgh, SSPO chief executive, said: “Having reviewed the WRc report on the Environmental Quality Standard for emamectin benzoate, published by SEPA this week, and having taken expert opinion on this, SSPO believes that the report’s recommendations are exceptionally precautionary and that there is a need for further relevant data to ensure proper balance is maintained.

“With this in mind, SSPO will set about gathering additional environmental information and will commission further independent research designed to fill existing gaps in information. These things will proceed as a matter of urgency. We will keep SEPA fully advised of our plans and provide them with the results of the research once it is available.”


The Health and Welfare of Atlantic Salmon course

It is vital that fish farm operatives who are responsible for farmed fish are trained in their health and welfare. This will help to ensure that fish are free from disease and suffering whilst at the same time promote good productivity and comply with legislation.

Find out more